HyperapoB
Showing 1 - 2 of 2
Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response Trial (Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1))
Completed
- Type 2 Diabetes
- +3 more
- Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)
- (no location specified)
Aug 3, 2020
Hyperapo B and Coronary Heart Disease
Completed
- Cardiovascular Diseases
- +5 more
- (no location specified)
Feb 17, 2016